ABT Stock Chart & Stats
$1766.86
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$1,413.00 - $2,810.32
Previous CloseN/A
VolumeN/A
Average Volume (3M)337.00
Market Cap
$3.14T
Enterprise Value$206.76K
Total Cash (Recent Filing)$7.29B
Total Debt (Recent Filing)$34.05B
Price to Earnings (P/E)33.2
Beta-0.34
Next Earnings
Oct 21, 2026EPS Estimate
24.81Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.60
Shares Outstanding1,741,812,400
10 Day Avg. Volume302
30 Day Avg. Volume337
Financial Highlights & Ratios
PEG Ratio-0.65
Price to Book (P/B)4.20
Price to Sales (P/S)4.94
P/FCF Ratio29.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2,096.68Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)96.54
Revenue Forecast (FY)$880.53B
ABT FAQ
What was Abbott Laboratories’s price range in the past 12 months?
Abbott Laboratories lowest stock price was $1413.00 and its highest was $2810.32 in the past 12 months.
What is Abbott Laboratories’s market cap?
Abbott Laboratories’s market cap is $3.14T.
When is Abbott Laboratories’s upcoming earnings report date?
Abbott Laboratories’s upcoming earnings report date is Oct 21, 2026 which is in 87 days.
How were Abbott Laboratories’s earnings last quarter?
Abbott Laboratories released its earnings results on Jul 16, 2026. The company reported $22.937 earnings per share for the quarter, beating the consensus estimate of $22.359 by $0.578.
Is Abbott Laboratories overvalued?
According to Wall Street analysts Abbott Laboratories’s price is currently Undervalued.
Does Abbott Laboratories pay dividends?
Abbott Laboratories does not currently pay dividends.
What is Abbott Laboratories’s EPS estimate?
Abbott Laboratories’s EPS estimate is 24.81.
How many shares outstanding does Abbott Laboratories have?
Abbott Laboratories has 1,741,812,400 shares outstanding.
What happened to Abbott Laboratories’s price movement after its last earnings report?
Abbott Laboratories reported an EPS of $22.937 in its last earnings report, beating expectations of $22.359. Following the earnings report the stock price went up 11.108%.
Which hedge fund is a major shareholder of Abbott Laboratories?
Currently, no hedge funds are holding shares in MX:ABT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Abbott Laboratories Stock Smart Score
Company Description
Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
ABT Company Deck
ABT Earnings Call
Q2 2026
0:00 / 0:00
ABT Net sales Breakdown
12.49% Established Pharmaceutical Products
19.06% Nutritional Products
20.16% Diagnostic Products
48.25% Medical Devices
0.04% Other

ABT Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$2,096.68